Endometriosis New Zealand is welcoming Pharmac's decision to publicly fund desogestrel, a move that will significantly improve access to this important treatment option for people living with ...
"This decision will be a major boost for many New Zealanders affected by endometriosis," says Tanya Cooke, Chief Executive of Endometriosis New Zealand. "For far too long, access to desogestrel, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results